Graham Capital Management, L.P. Axsome Therapeutics, Inc. Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $662,882 - $932,754	9,553 New	9,553 $762,000
Q3 2023 Nov 22, 2023	BUY	$69.25 - $82.21 $917,908 - $1.09 Million	13,255 New	13,255 $926,000
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $2.21 Million - $4.76 Million	-101,851 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $1.86 Million - $3.25 Million	78,518 Added 336.51%	101,851 $4.22 Million
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $716,323 - $1.01 Million	23,333 New	23,333 $881,000

326

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.